Tokyo, Feb 5, 2007 (JCN) - Olympus Medical Systems announced the release of Olympus Gif Type RQ260Z
Evis Lucera - a digestive tract video scope used for observing of blood vessels in mucous membranes under infrared light.
Blood vessels are observed this way to assess how far tumors have invaded and therefore how best to treat a particular patient's stomach cancer. Infiltration of the cancer can be deduced by the proliferation of blood cells in the gastrointestinal mucous membranes.
The Evis Lucera video scope comes with a 90x zoom and a button that allows it to switch from normal to narrow band imaging. This special light setting, caused by irradiation of two hemoglobin-absorbed wavelengths, is used to display capillary blood vessels and mucous membranes patterns.
The Evis Lucera will be available from the beginning of February, 2007.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
 |
|
Announcement Regarding Establishment of Medical Business Venture Company between Olympus and Sony
(Apr 3, 2013)
|
|
|
Olympus Establishes India Subsidiary
(Nov 4, 2010)
|
|
|
Digital Camera Sales up 25% from Year Earlier on Economy Models
(Aug 13, 2010)
|
|
|
Olympus to Acquire U.S. Pulmonary Device Company Spiration
(June 25, 2010)
|
|
|
Olympus Launches Nondestructive Testing Instrument
(June 2, 2010)
|
|
|
Olympus "Joint update service for Four Thirds lenses" launched
(Oct 15, 2008)
|
|
|
Olympus Imaging and Panasonic Announce New Micro Four Thirds System Standard
(Aug 5, 2008)
|
|
|
Olympus Imaging: The World's Thinnest and Smallest DSLR
(May 12, 2008)
|
|
|
Olympus to Bolster Medical Biz thru M&As: President
(Mar 19, 2008)
|
|
|
Olympus Cuts FY '07 Estimates on Slow Digital Camera Sales
(Feb 5, 2008)
|
|
|
|
|
|
|
Fujifilm Initiates Phase I Clinical Trial in Japan for Anticancer Agent FF-10501 (June 7, 2013)
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
More Medical news...
|
|
|
|
|
|
Fujifilm Initiates Phase I Clinical Trial in Japan for Anticancer Agent FF-10501 (June 7, 2013)
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
More Medical news...
|
|
